Cyclopharm Limited (CYC.AX)
Makes diagnostic imaging equipment and radioactive medicines for detecting lung diseases.
0.60+0.14%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-42.8%
The outlook
CYC.AX is trading near the lower end of its 52-week range, with a mixed short-term trend. Analyst coverage shows an average price target roughly 68% above current levels, though the overall StockGlow score is neutral, reflecting mixed signals in the data.
What’s behind the score
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +68% vs current price
Market cap
$74.8M
52-wk high
1.29
52-wk low
0.45
50-day avg
0.58
200-day avg
0.77
Trailing P/E
—